Moroxite F
Developing next generation therapeutics in osteoporosis.
Developing next generation therapeutics in osteoporosis.
Moroxite F is a med-tech company founded in 2021 and based in Sweden with the slogan "Developing next generation therapeutics in osteoporosis." The company is dedicated to developing a regenerative medicine approach to improve implant anchorage in fragile bone and reduce re-operations. Their innovative approach involves a biphasic ceramic material containing apatite particles, a novel drug delivery method to augment fracture fixation, and an effective device. The company recently secured a significant kr10.00M Venture Round investment on 18 February 2022 from Almi Invest and Fåhraeus Startup and Growth. With its focus on addressing critical needs within the Health Care industry, Moroxite F exhibits potential in revolutionizing osteoporosis treatment and enhancing the overall quality of care for patients.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | kr10.00M | 2 |
|
18 Feb 2022 |
No recent news or press coverage available for Moroxite F.
We care about your data, and we'd love to use cookies make your experience better.